Practice Management News

A nutritional program that focused on increased intake of prebiotics and probiotics improved cardiometabolic health in patients with schizophrenia spectrum disorders, according to a study published in BMC Psychiatry.

The FDA has granted Vistagen fast track designation for PH10, a nasal spray for the treatment of major depressive disorder, according to a company press release.

The Residency to Retirement resource center offers insightful and innovative strategies to help physicians reduce taxes, protect assets, invest wisely and build wealth during all phases of their careers.

Cebranopadol, a pain relief drug, showed low potential for abuse among nondependent recreational opioid users compared with tramadol or oxycodone, researchers from Tris Pharma Inc. stated in a press release.

Telehealth interventions were as effective as in-person treatment for reducing anxiety and depressive symptoms, according to data published in BMC Psychiatry.

In October, the U.S. Preventive Services Task Force released a final recommendation advocating for anxiety screening in asymptomatic youth aged 8 to 18 years and major depressive disorder screening in asymptomatic youth aged 12 to 18 years.

New data suggest a link between consumption of theobromine, a primary ingredient in chocolate, and an increased risk for depression.

Costs associated with mental health telehealth for adolescents have skyrocketed since 2019, according to research from Nomi Health.

Individuals with alcohol use disorder showed consistent engagement with a prescription digital therapeutic and displayed a high level of abstinence, per a poster presented at the American Association of Addiction Psychiatry annual meeting.

For individuals who make medically serious suicide attempts, those that require admission to intensive care units should be considered similar to those which result in suicide, researchers wrote in a study published in BMC Psychiatry.